| Checkpoint inhibitors in pancreatic cancer A Henriksen, A Dyhl-Polk, I Chen, D Nielsen Cancer treatment reviews 78, 17-30, 2019 | 186 | 2019 |
| Clinical value of serum hyaluronan and propeptide of type III collagen in patients with pancreatic cancer IM Chen, N Willumsen, C Dehlendorff, AZ Johansen, BV Jensen, ... International Journal of Cancer 146 (10), 2913-2922, 2020 | 49 | 2020 |
| Ultrasensitive plasma ctDNA KRAS assay for detection, prognosis, and assessment of therapeutic response in patients with unresectable pancreatic ductal adenocarcinoma I Chen, VM Raymond, JA Geis, EA Collisson, BV Jensen, KL Hermann, ... Oncotarget 8 (58), 97769, 2017 | 39 | 2017 |
| Effects of a 12-week multimodal exercise intervention among older patients with advanced cancer: results from a randomized controlled trial MK Mikkelsen, CM Lund, A Vinther, A Tolver, JS Johansen, I Chen, ... The oncologist 27 (1), 67-78, 2022 | 38 | 2022 |
| Prognostic impact of Charlson’s Age‐Comorbidity Index and other risk factors in patients with pancreatic cancer K Bagni, IM Chen, AZ Johansen, C Dehlendorff, BV Jensen, CP Hansen, ... European Journal of Cancer Care 29 (3), e13219, 2020 | 37 | 2020 |
| Seeding after ultrasound-guided percutaneous biopsy of liver metastases in patients with colorectal or breast cancer I Chen, T Lorentzen, D Linnemann, CP Nolsøe, B Skjoldbye, BV Jensen, ... Acta Oncologica 55 (5), 638-643, 2016 | 25 | 2016 |
| Collagen biomarkers quantify fibroblast activity in vitro and predict survival in patients with pancreatic ductal adenocarcinoma NI Nissen, AZ Johansen, I Chen, JS Johansen, RS Pedersen, CP Hansen, ... Cancers 14 (3), 819, 2022 | 18 | 2022 |
| Prognostic value of combined detection of serum IL6, YKL-40, and C-reactive protein in patients with unresectable pancreatic cancer IM Chen, AZ Johansen, C Dehlendorff, BV Jensen, SE Bojesen, P Pfeiffer, ... Cancer Epidemiology, Biomarkers & Prevention 29 (1), 176-184, 2020 | 17 | 2020 |
| Engaging the older cancer patient; Patient Activation through Counseling, Exercise and Mobilization–Pancreatic, Biliary tract and Lung cancer (PACE-Mobil-PBL)-study protocol of … MK Mikkelsen, CM Lund, A Vinther, A Tolver, AM Ragle, JS Johansen, ... BMC cancer 18, 1-11, 2018 | 12 | 2018 |
| Identification of new biomarkers in patients with pancreatic cancer (BIOPAC): a study protocol of an open cohort study I Chen, BV Jensen, SE Bojesen, AZ Johansen, NA Schultz, CP Hansen, ... Journal of Cancer Science and Therapy 11 (8), 232, 2019 | 11 | 2019 |
| PACTO: A single center, randomized, phase II study of the combination of nab-paclitaxel and gemcitabine with or without tocilizumab, an IL-6R inhibitor, as first-line treatment … I Chen, JS Johansen, TA Zimmers, C Dehlendorff, VK Parner, BV Jensen, ... Annals of Oncology 28, v266, 2017 | 11 | 2017 |
| Disparity in use of modern combination chemotherapy associated with facility type influences survival of 2655 patients with advanced pancreatic cancer M Ladekarl, LS Rasmussen, J Kirkegård, I Chen, P Pfeiffer, B Weber, ... Acta Oncologica 61 (3), 277-285, 2022 | 6 | 2022 |
| Long-term results after resection of primary duodenal adenocarcinoma: A retrospective cohort study KK Jensen, JH Storkholm, I Chen, SK Burgdorf, CP Hansen International Journal of Surgery 100, 106599, 2022 | 5 | 2022 |
| Chitooligosaccharides improve the efficacy of checkpoint inhibitors in a mouse model of lung cancer AZ Johansen, M Carretta, ML Thorseth, S Khan, KY Fjæstad, CB Brøchner, ... Pharmaceutics 14 (5), 1046, 2022 | 4 | 2022 |
| Serum interleukin-6 as a prognostic biomarker for survival in patients with unresectable pancreatic cancer I Chen, C Dehlendorff, BV Jensen, P Pfeiffer, SE Nielsen, NH Holländer, ... Annals of Oncology 27, vi26, 2016 | 3 | 2016 |
| Prognostic value of plasma circulating tumor (ct) DNA KRAS mutations and serum CA19-9 in unresectable pancreatic cancer (PC) patients. JS Johansen, CRT Vibat, S Hancock, IM Chen, L Hassaine, E Samuelsz, ... Journal of Clinical Oncology 33 (15_suppl), 4022-4022, 2015 | 3 | 2015 |
| Prognostic and diagnostic value of serum hyaluronan in patients with pancreatic carcinoma. I Chen, C Dehlendorff, AZ Johansen, BV Jensen, MB Krüger, P Pfeiffer, ... Journal of Clinical Oncology 36 (15_suppl), e16249-e16249, 2018 | 1 | 2018 |
| Detection and quantitation of ctDNA KRAS mutations from patients with unresectable pancreatic cancer I Chen, VM Raymond, J Geis, S Pingle, FFBEA Collisson, V Melnikova, ... | 1 | 2016 |
| Liquid biopsy approaches for monitoring metastatic pancreatic cancer in immunotherapy treated patients CA Hruban, I Chen, DC Bruhm, S Koul, J Yao, S Theile, K Boyapati, ... Cancer Research 84 (6_Supplement), 2422-2422, 2024 | | 2024 |
| PLASMA YKL-40 IS ASSOCIATED WITH PROGNOSIS IN PATIENTS WITH METASTATIC PANCREATIC CANCER RECEIVING IMMUNE CHECKPOINT INHIBITORS IN COMBINATION WITH RADIOTHERAPY A Johansen, S Novitski, J Hjaltelin, S Theile, M Boisen, S Brunak, ... JOURNAL FOR IMMUNOTHERAPY OF CANCER 10, A151-A151, 2022 | | 2022 |
